Literature DB >> 2877986

Bordetella pertussis adenylate cyclase. Purification, characterization, and radioimmunoassay.

D Ladant, C Brezin, J M Alonso, I Crenon, N Guiso.   

Abstract

The extracellular adenylate cyclase of Bordetella pertussis was purified either as a free enzyme or as a complex with calmodulin. The purified enzyme has a specific activity of 1600 mumol of cAMP min-1 X mg-1 and exists under two molecular forms of 45 and 43 kDa which are apparently structurally related. Calmodulin increased considerably the resistance of adenylate cyclase to inactivation by trypsin. Although trypsin cleaved the adenylate cyclase-calmodulin complex, the digested fragments remained associated by noncovalent interactions in an active conformation. Specific mouse anti-adenylate cyclase antibodies inhibit adenylate cyclase activity and were used to develop a specific radioimmunoassay that allows detection of as little as 5 ng of adenylate cyclase in culture supernatants.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2877986

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years.

Authors:  C Weber; C Boursaux-Eude; G Coralie; V Caro; N Guiso
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

2.  Comparison of the Bordetella pertussis and Bordetella parapertussis isolates circulating in Saint Petersburg between 1998 and 2000 with Russian vaccine strains.

Authors:  Natacha Kourova; Valérie Caro; Christian Weber; Sabine Thiberge; Raisa Chuprinina; Galina Tseneva; Nicole Guiso
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

3.  Characterization of adenylate cyclase-hemolysin gene duplication in a Bordetella pertussis isolate.

Authors:  Karine Dalet; Christian Weber; Laurent Guillemot; Elisabeth Njamkepo; Nicole Guiso
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

4.  Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells.

Authors:  Pádraig J Ross; Ed C Lavelle; Kingston H G Mills; Aoife P Boyd
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

5.  Deletions affecting hemolytic and toxin activities of Bordetella pertussis adenylate cyclase.

Authors:  J Bellalou; H Sakamoto; D Ladant; C Geoffroy; A Ullmann
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

Review 6.  Pertussis: the disease and new diagnostic methods.

Authors:  R L Friedman
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

7.  Bordetella pertussis adenylate cyclase inactivation by the host cell.

Authors:  A Gilboa-Ron; A Rogel; E Hanski
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

8.  The C-terminal domain is essential for protective activity of the Bordetella pertussis adenylate cyclase-hemolysin.

Authors:  F Betsou; P Sebo; N Guiso
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  Virulence of Bordetella bronchiseptica: role of adenylate cyclase-hemolysin.

Authors:  P Gueirard; N Guiso
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

10.  Human Bordetella bronchiseptica infection related to contact with infected animals: persistence of bacteria in host.

Authors:  P Gueirard; C Weber; A Le Coustumier; N Guiso
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.